In parallel, CAF-released hepatocyte growth factor (HGF) activates c-Met in tumor cells, leading to metabolic rewiring through modulation of glycolytic enzymes such as hexokinase-II and phosphofructokinase, alongside increased MCT1 activity. The gene discussed is HGF; the disease is neoplasm.